This third session on the “Sources of life sciences regulation” is intended to provide the participants with a high-level overview of the pharmacovigilance legislation in the European Union and will include a specific part on the Belgian legislation.

In this session, we will explore how value-based healthcare (VBHC) provides a philosophy and instrument to redirect our healthcare system.  Prof. Brecht Cardoen, Vlerick business school & KU Leuven, will sketch the theoretical framework on VBHC and its implementation. Prof. Dr. Jo Lambert, UZ Gent, illustrates this with real life examples from her own practice.

In recent years an increasing share of clinical research is being conducted outside of the traditional markets such as US and Europe. With this webinar we would like to better understand these shifting dynamics by focusing on two countries in particular. The aim is to look at capacity building, to assess strengths and weaknesses of emerging markets for research and how this relates to what makes Belgium attractive today.

Join us for an inspirational talk and a networking drink to kick off 2023! Keynote: Wellbeing is key for business succes, by Gert Braeken, author of 'Het burn-outvaccin'.

From January 2023 onwards all clinical trial applications, including phase 1 trials, need to be submitted according to the new Clinical Trial Regulation (CTR). In this meeting, all stakeholders are brought together and given the opportunity to express their perceived challenges and opportunities as we move into this new legislative framework.

Online conference. This training course is intended for both manufacturers and distributors of medical devices/ in vitro medical devices and will address various questions/issues under the MDR/IVDR.